Peer-Reviewed Publication
Infection2025;53(3):981-989.June 1, 2025Journal Article
Comparison of SARS-CoV-2 related in-hospital mortality, ICU admission and mechanical ventilation of 1.4 million patients in Germany and Switzerland, 2019 to 2022.
Cathrin Kodde1,2, Sven Hohenstein3, Irit Nachtigall4,5, Yvonne Cavalli6,7, Reto Schuepbach8, Raphael Graf9, Andreas Bollmann3,10, Ralf Kuhlen3,7
1Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitaetsmedizin Berlin, Berlin, Germany. cathrin.kodde@charite.de.
2Department of Respiratory Diseases, Lungenklinik Heckeshorn, Helios Hospital Emil-Von-Behring, Berlin, Germany. cathrin.kodde@charite.de.
3Helios Health Institute, Berlin, Germany.
4Department of Infectious Diseases and Infection Prevention, Helios Hospital Emil-Von-Behring, Berlin, Germany.
5Faculty of Medicine, MSB Medical School Berlin, Berlin, Germany.
6University Hospital Zurich, Zurich, Switzerland.
7Initiative Quality Medicine, Berlin, Germany.
8Institute of Intensive Care Medicine, University Hospital Zurich and University Zurich, Zurich, Switzerland.
93M Health Information Systems, Neuss, Germany.
10Department of Electrophysiology, Heart Centre Leipzig at University of Leipzig, Leipzig, Germany.
Abstract
PURPOSE: In the 2020 emergence of SARS-CoV-2, global response lacked unified treatment and surveillance, resulting in diverse impacts due to varied healthcare resources and national guidelines. Germany and Switzerland curbed the virus initially by promptly tracking and testing, bolstered by strong governmental capacity. This study aimed to assess country-specific healthcare disparities and their i…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans